A comparative study of antibacterial effects of mouthwashes containing Ag/ZnO or ZnO nanoparticles with chlorhexidine and investigation of their cytotoxicity

Document Type : Research Paper

Authors

1 Department of Orthodontics, Faculty of Dentistry, Tabriz University of Medical Sciences

2 Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3 Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

4 Operative Dentistry Department, Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran

5 Dentistry student ,Faculty of Dentistry , Tabriz University of Medical Sciences, Tabriz ,Iran

Abstract

Objective(s): Chlorhexidine 0.2% mouthwash is commonly used in orthodontic patients for plaque control. But it has some side effects. Metal oxide nanoparticles have been recently used in mouthwashes in reports. So we aimed to evaluate antibacterial effect of ZnO and Ag/ZnO nanoparticles against Streptococcus mutans and compare them with chlorhexidine 0.2%, sodium fluoride 0.05% and some of their compositions.
Materials and Methods: ZnO and Ag/ZnO NPs were synthesized and sixteen groups of mouthwashes were prepared. We used Zone of Inhibition (ZOI) test to evaluation of antibacterial effects of as-prepared mouthwashes, against S. mutans. The cytotoxicity of the ZnO and Ag/ZnO NPs were investigated in the A549 cell line.
Results: Among the study groups, the maximum ZOI (16.60±0.49 mm) pertained to Ag/ZnO, 10 mg NPs plus 100 ml base material, (Ag/ZnO b 10). The results indicate that no significant harmful effect is imposed to the cells up to 0.2 mg/ml of ZnO and Ag/ZnO NPs.
Conclusion: Results showed that mouthwash containing Ag/ZnO b 10 has the highest antibacterial properties against S .mutans amoung study groups and because in this concentration it is safe for cells, so it can be served as an alternative mouthwash in plaque control instead of chlorhexidine 0.2% after in vivo studies.

Keywords

References

1.Behnan M, Arruda AO, González-Cabezas C, Sohn W, Peters MC. In-vitro evaluation of various treatments to prevent demineralization next to orthodontic brackets. Am J Orthod Dentofac Orthop. 2010; 138(6): 712.e1–712.e7.
2.Wennström JL, Heijl L, Dahlén G, Gröndahl K. Periodic subgingival antimicrobial irrigation of periodontal pockets. J Clin Periodontol. 1987; 14(9): 541-550.
3.Renton-Harper P, Addy M, Moran J, Doherty FM, Newcombe RG. A comparison of chlorhexidine, cetylpyridinium chloride, triclosan, and C31G mouthrinse products for plaque inhibition. J Periodontol. 1996; 67(5): 486-589.
4.Almas K. The effect of Salvadora persica extract (miswak) and chlorhexidine gluconate on human dentin: a SEM study. J Contemp Dent Pract. 2002; 3(3): 27-35.
5.Kabil NS, Badran AS, Wassel MO. Effect of the addition of chlorhexidine and miswak extract on the clinical performance and antibacterial properties of conventional glass ionomer: an in vivo study. Int J Paediatr Dent. 2017; 27(5): 380-387.
6.Anderson GB, Bowden J, Morrison EC, Caffesse RG. Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. Am J Orthod Dentofacial Orthop. 1997; 111(6): 606-612.
7.Shah HM, Shah MN, Gokani VN, Jethal BS. A comparative, qualitative and quantitative antimicrobial efficacies of mouthrinses containing chlorhexidine gluconate and essential oils. Indian J Dent Res. 1993; 4(3-4): 103-111.
8.Fejerskov O, Kidd E, editors. Dental caries: the disease and its clinical management. John Wiley & Sons; 2009.
9.Phan TN, Buckner T, Sheng J, Baldeck JD, Marquis RE. Physiologic actions of zinc related to inhibition of acid and alkali production by oral streptococci in suspensions and biofilms. Mol Oral Microbiol. 2004; 19(1): 31-38.
10.O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol. 1972; 43(1):38.
11.Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine. 2017; 12: 1227–1249.
12.Hernández-Sierra JF, Ruiz F, Pena DC, Martínez-Gutiérrez F, Martínez AE, Guillén AD, Tapia-Pérez H, Castañón GM. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine. 2008; 4(3): 237-240.
13.Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology. 2007; 18(22):225103- 225111.
14.Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005; 16(10): 2346 –2353.
15.Giertsen E. Effects of mouthrinses with triclosan, zinc ions, copolymer, and sodium lauryl sulphate combined with fluoride on acid formation by dental plaque in vivo. Caries Res. 2004; 38(5): 430-435.
16.Roldan S, Herrera D, O'connor A, González I, Sanz M. A combined therapeutic approach to manage oral halitosis: a 3-month prospective case series. J Periodontol. 2005; 76(6): 1025-1033.
17.Li M, Zhu L, Lin D. Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci Technol. 2011; 45(5): 1977-1983.
18.Burguera-Pascu M, Rodríguez-Archilla A, Baca P. Substantivity of zinc salts used as rinsing solutions and their effect on the inhibition of Streptococcus mutans. J Trace Elem Med Biol. 2007; 21(2): 92-101.
19.Dobl P, Nossek H. The effect of zinc chloride mouthwashes on caries-inducing plaque streptococci. 2. In vivo studies of the antibacterial effect of zinc chloride on the total streptococcal flora of the dental plaque. Dtsch Zahn Mund Kieferheilkd Zentralbl. 1990; 78(5): 393-396.
20.Samiei M, Ghasemi N, Asl-Aminabadi N, Divband B, Golparvar-Dashti Y, Shirazi S. Zeolite-silver-zinc nanoparticles: Biocompatibility and their effect on the compressive strength of mineral trioxide aggregate. J Clin Exp Dent. 2017; 9(3): e356-360.
21.Ahrari F, Eslami N, Rajabi O, Ghazvini K, Barati S. The antimicrobial sensitivity of Streptococcus mutans and Streptococcus sangius to colloidal solutions of different nanoparticles applied as mouthwashes. J Dent Res. 2015; 12(1): 44-49.
22.Kachoei M, Nourian A, Divband B, Kachoei Z, Shirazi S. Zinc-oxide nanocoating for improvement of the antibacterial and frictional behavior of nickel-titanium alloy. Nanomedicine. 2016; 11(19): 2511–2527
23.Yavari H , Ghasemi N, Divband B, Rezaei Y, Jabbari G, Payahoo S. The effect of photodynamic therapy and polymer solution containing nano-particles of Ag /ZnO on push-out bond strength of the sealers AH-Plus and MTA Fillapex. J Clin Exp Dent. 2017; 9(9): e1109-1114.
24.Samiei M, Ghasemi N, Divband B, Balaei E, Soroush Barhaghi M H, Divband A. Antibacterial efficacy of polymer containing nanoparticles in comparison with sodium hypochlorite in infected root canals. Minerva Stomatol. 2015; 64: 275-281.
25.Khatamian M, Divband B, Daryan M. Preparation, characterization and antimicrobial property of ag+-nano Chitosan/ZSM-5: novel Hybrid Biocomposites. Nanomed J. 2016; 3(4):268-279.
26.Li WR, Xie XB, Shi QS, Zeng HY, You-Sheng OY, Chen YB. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol. 2010; 85(4): 1115-1122.
27.Marambio-Jones C, Hoek EM. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res. 2010; 12(5): 1531-1551.
28.Kim KJ, Sung WS, Suh BK, Moon SK, Choi JS, Kim JG, Lee DG. Antifungal activity and mode of action of silver nano-particles on Candida albicans. BioMetals. 2009; 22(2): 235-242.
29.Gomes-Filho JE, Silva FO, Watanabe S, Cintra LT, Tendoro KV, Dalto LG, Pacanaro SV, Lodi CS, de Melo FF. Tissue reaction to silver nanoparticles dispersion as an alternative irrigating solution. J Endod. 2010; 36(10): 1698-1702.
30.Yang W, Shen C, Ji Q, An H, Wang J, Liu Q, Zhang Z. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology. 2009; 20(8): 085102.
31.Schilling K, Bradford B, Castelli D, Dufour E, Nash JF, Pape W, Schulte S, Tooley I, van den Bosch J, Schellauf F. Human safety review of “nano” titanium dioxide and zinc oxide. Photochem Photobiol Sci. 2010; 9(4): 495-509.
32.Adams LK, Lyon DY, Alvarez PJ. Comparative eco-toxicity of nanoscaleTiO 2, SiO 2, and ZnO water suspensions. Water Res. 2006; 40(19): 3527-3532.
33.Ghosh S, Goudar VS, Padmalekha KG, Bhat SV, Indi SS, Vasan HN. ZnO/Ag nanohybrid: synthesis, characterization, synergistic antibacterial activity and its mechanism. RSC Adv. 2012; 2(3): 930-940.
34.Divband B, Khatamian M, Eslamian GK, Darbandi M. Synthesis of Ag/ZnO nanostructures by different methods and investigation of their photocatalytic efficiency for 4-nitrophenol degradation. Appl Surf Sci. 2013; 284: 80-86.
35.Wang S, Wu J, Yang H, Liu X, Huang Q, Lu Z. Antibacterial activity and mechanism of Ag/ZnO nanocomposite against anaerobic oral pathogen Streptococcus mutans. J Mater Sci: Mater Med. 2017; 28: 23.
36.Michalek SM, Hirasawa M, Kiyono H, Ochiai K, McGhee JR. Oral ecology and virulence of Lactobacillus casei and Streptococcus mutans in gnotobiotic rats. Infect Immun. 1981; 33(3): 690-696.
37.Hernández-Sierra JF, Ruiz F, Pena DC, Martínez-Gutiérrez F, Martínez AE, Guillén AD, Tapia-Pérez H, Castañón GM. The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold. Nanomedicine. 2008; 4(3): 237-240.
38.Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005; 16(10): 2346.
39.Burguera-Pascu M, Rodríguez-Archilla A, Baca P. Substantivity of zinc salts used as rinsing solutions and their effect on the inhibition of Streptococcus mutans. J Trace Elem Med Biol. 2007; 21(2): 92-101.
40.R. Sadeghi, P. Olia, MB. Rezvani, F. Taleghani, F.Sharif. Comparison of the nanosilver and chlorhexidin antimicrobial effect on Streptococcus sangius and actinomicosis viscosus. J Islamic Dent Assoc. 2010; 23: 225-231.
41.Marsh PD, Keevil CW, McDermid AS, Williamson MI, Ellwood DC. Inhibition by the antimicrobial agent chlorhexidine of acid production and sugar transport in oral streptococcal bacteria. Arch Oral Biol. 1983; 28(3): 233-240.
42.Ahamed M, Akhtar MJ, Raja M, Ahmad I, Siddiqui MK, AlSalhi MS, Alrokayan SA. ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress. Nanomedicine. 2011; 7(6): 904-913.
43.Pandurangan M, Kim DH. In vitro toxicity of zinc oxide nanoparticles: a review. J Nanopart Res. 2015; 17(3):158.
44.Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett DG. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res Lett. 2009; 4(12): 1409-1420.
45.Zhang Y, Nguyen KC, Lefebvre DE, Shwed PS, Crosthwait J, Bondy GS, Tayabali AF. Critical experimental parameters related to the cytotoxicity of zinc oxide nanoparticles. J Nanopart Res. 2014; 16(6): 2440. 
Nanomedicine Journal
Volume 5, Issue 2
April 2018
Pages 102-110

Files

Share

How to cite

Statistics